Cargando…

Prevalencia de las cardiopatías congénitas en relación con la altura sobre el nivel del mar en una región de Colombia

INTRODUCTION: Congenital heart diseases are the most common congenital disorders in the world population, they generally manifest after birth. Altitudes between 2,500-3,500 meters above sea level have been linked to the high incidence of congenital heart diseases such as patent ductus arteriosus, at...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez-Monroy, Carlos A., Hoyos-Gómez, Laura K., Acosta-Costilla, Álvaro F., Muñoz-Torres, Laura D., Fernández-Ávila, Daniel G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Permanyer Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161842/
https://www.ncbi.nlm.nih.gov/pubmed/36757777
http://dx.doi.org/10.24875/ACM.21000325
Descripción
Sumario:INTRODUCTION: Congenital heart diseases are the most common congenital disorders in the world population, they generally manifest after birth. Altitudes between 2,500-3,500 meters above sea level have been linked to the high incidence of congenital heart diseases such as patent ductus arteriosus, atrial septum defects, and ventricular septum defects. OBJETIVES: To characterize clinically and sociodemographically the patients diagnosed with congenital heart disease from low, moderate and high altitudes in a regional hospital in Colombia. METHODOLOGY: Observational, descriptive retrospective study. All patients under 18 years of age with a diagnosis of congenital heart disease, treated at the San Rafael de Tunja University Hospital between 2015 and 2021, were included. RESULTS: 51.9% of the patients were male, 16.3% had a history of prematurity and 9.1% had a diagnosis of Down syndrome. The most frequent heart diseases were: persistent ductus arteriosus 35.1%, followed by ventricular communication representing 21.6% and intra-atrial communication with 19.7%). CONCLUSIONS: They must eestablish strategies such as screening and timely diagnosis of congenital heart disease in at-risk populations in order to improve the life prognosis of patients and the outcome of the disease.